一种用于化学动力学癌症治疗和激活抗肿瘤免疫的基于DNA折纸的酶促级联纳米反应器。
A DNA origami-based enzymatic cascade nanoreactor for chemodynamic cancer therapy and activation of antitumor immunity.
作者信息
Jiao Yunfei, Wang Haiyan, Wang Hong, Xie Yiming, Shang Yingxu, Wu Yushuai, Guo Xinqing, Yu Shuhui, Li Na, Ding Baoquan
机构信息
CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
出版信息
Sci Adv. 2025 Jan 10;11(2):eadr9196. doi: 10.1126/sciadv.adr9196. Epub 2025 Jan 8.
Chemodynamic therapy (CDT) is a promising and potent therapeutic strategy for the treatment of cancer. We developed a DNA origami-based enzymatic cascade nanoreactor (DOECN) containing spatially well-organized Au nanoparticles and ferric oxide (FeO) nanoclusters for targeted delivery and inhibition of tumor cell growth. The DOECN can synergistically promote the generation of hydrogen peroxide (HO), consumption of glutathione, and creation of an acidic environment, thereby amplifying the Fenton-type reaction and producing abundant reactive oxygen species, such as hydroxyl radicals (•OH), for augmenting the CDT outcome. The DOECN is decorated with targeting groups to achieve efficient cellular uptake and efficiently induce tumor cell apoptosis, ferroptosis, and immunogenetic cell death, thus realizing potent anticancer therapeutic effects. Intravenous injection of the DOECN effectively promoted the maturation of dendritic cells, triggered adaptive T cell responses, and suppressed tumor growth in a murine cancer model. The DOECN provides a programmable platform for the integration of multiple therapeutic components, showing great potential for combined cancer therapy.
化学动力学疗法(CDT)是一种很有前景且有效的癌症治疗策略。我们开发了一种基于DNA折纸的酶促级联纳米反应器(DOECN),其包含空间组织良好的金纳米颗粒和氧化铁(FeO)纳米簇,用于靶向递送并抑制肿瘤细胞生长。DOECN能够协同促进过氧化氢(HO)的生成、谷胱甘肽的消耗以及酸性环境的形成,从而放大芬顿型反应并产生大量活性氧物种,如羟基自由基(•OH),以增强CDT效果。DOECN装饰有靶向基团,以实现高效的细胞摄取并有效诱导肿瘤细胞凋亡、铁死亡和免疫原性细胞死亡,从而实现强大的抗癌治疗效果。在小鼠癌症模型中,静脉注射DOECN可有效促进树突状细胞成熟,触发适应性T细胞反应并抑制肿瘤生长。DOECN为多种治疗成分的整合提供了一个可编程平台,在联合癌症治疗中显示出巨大潜力。